

In adults 65 to 79 years of age, there appeared to be fewer hospitalizations for influenza or pneumonia with high-dose influenza vaccine than with the standard dose, with a similar incidence of serious adverse events.
Geriatrics/Aging
|11th Mar, 2026
|The New England Journal of Medicine
Geriatrics/Aging
|11th Mar, 2026
|The New England Journal of Medicine
Geriatrics/Aging
|11th Mar, 2026
|The New England Journal of Medicine
Geriatrics/Aging
|11th Mar, 2026
|The New England Journal of Medicine
Geriatrics/Aging
|11th Mar, 2026
|The New England Journal of Medicine
Geriatrics/Aging
|11th Mar, 2026
|The New England Journal of Medicine
Geriatrics/Aging
|11th Mar, 2026
|The New England Journal of Medicine